{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:24:50Z","timestamp":1787293490661,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jfma.2026.08.032","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T05:46:04Z","timestamp":1787291164000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical utilization of CPET in obesity-associated unexplained exertional dyspnea: Narrative review and expert perspective"],"prefix":"10.1016","author":[{"given":"Fa-Chang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho-Kai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hsien","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chung","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Chun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Hsiean","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ti","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2858-3493","authenticated-orcid":false,"given":"Chung-Lieh","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2026.08.032_bib1","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jfma.2024.02.008","article-title":"A non-invasive nomogram for predicting heart failure with preserved ejection fraction in Taiwanese outpatients with unexplained dyspnea and fatigue","volume":"123","author":"Chung","year":"2024","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2026.08.032_bib2","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/ejhf.2601","volume":"24","author":"Guazzi","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.jfma.2026.08.032_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010618","article-title":"Obesity-related biomarkers are associated with exercise intolerance and HFpEF","volume":"16","author":"Ramirez","year":"2023","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.jfma.2026.08.032_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011366","article-title":"Uncovering unrecognized heart failure with preserved ejection fraction among individuals with obesity and dyspnea","volume":"17","author":"Kosyakovsky","year":"2024","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jfma.2026.08.032_bib5","doi-asserted-by":"crossref","first-page":"H1126","DOI":"10.1152\/ajpheart.00587.2025","article-title":"Mechanisms of exercise limitation in heart failure with preserved ejection fraction and obesity: a case of engine-chassis mismatch","volume":"329","author":"Foulkes","year":"2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.jfma.2026.08.032_bib6","first-page":"148","article-title":"Guidelines of the Taiwan Society of Cardiology for the diagnosis and treatment of heart failure with preserved ejection fraction","volume":"40","author":"Li","year":"2024","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.jfma.2026.08.032_bib7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ehf2.15059","article-title":"Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides","volume":"12","author":"Berthelot","year":"2025","journal-title":"ESC Heart Fail"},{"issue":"16","key":"10.1016\/j.jfma.2026.08.032_bib8","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jacc.2025.06.055","article-title":"The adipokine hypothesis of heart failure with a preserved ejection fraction: a novel framework to explain pathogenesis and guide treatment","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2026.08.032_bib9","article-title":"Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction","volume":"8","author":"Sarma","year":"2020","journal-title":"Phys Rep"},{"issue":"8","key":"10.1016\/j.jfma.2026.08.032_bib10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jchf.2020.04.016","article-title":"Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction","volume":"8","author":"Koepp","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10.1016\/j.jfma.2026.08.032_bib11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/cvr\/cvaf056","article-title":"The role of epicardial adipose tissue remodelling in HFpEF","volume":"121","author":"Janssen-Telders","year":"2025","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jfma.2026.08.032_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12872-015-0136-8","article-title":"The association among MDCT-derived three-dimensional visceral adiposities on cardiac diastology and dyssynchrony in asymptomatic population","volume":"15","author":"Lai","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jfma.2026.08.032_bib13","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.124.072156","article-title":"Evidence-based application of natriuretic peptides in the evaluation of chronic heart failure with preserved ejection fraction in the ambulatory outpatient setting","volume":"151","author":"Reddy","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2026.08.032_bib19","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3389\/fphys.2019.01470","article-title":"Stress echocardiography-derived E\/e\u2032 predicts abnormal exercise hemodynamics in heart failure with preserved ejection fraction","volume":"10","author":"Chen","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.jfma.2026.08.032_bib20","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00330-023-10142-z","article-title":"Post-exercise left atrial conduit strain predicted hemodynamic change in heart failure with preserved ejection fraction","volume":"34","author":"Cheng","year":"2024","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.jfma.2026.08.032_bib14","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1086\/683815","article-title":"Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice","volume":"5","author":"Berry","year":"2015","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jfma.2026.08.032_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1466153","article-title":"Characteristics of cardiopulmonary exercise capacity in adults with different degrees of obesity","volume":"15","author":"Deng","year":"2025","journal-title":"Front Physiol"},{"issue":"5","key":"10.1016\/j.jfma.2026.08.032_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bjsports-2024-108748","article-title":"Cardiorespiratory fitness, body mass index and mortality: a systematic review and meta-analysis","volume":"59","author":"Weeldreyer","year":"2025","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jfma.2026.08.032_bib17","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1111\/dom.15877","article-title":"The prognostic role of cardiopulmonary exercise testing in obesity","volume":"26","author":"Borghi-Silva","year":"2024","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.jfma.2026.08.032_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.037290","article-title":"Chronotropic incompetence and cardiovascular outcomes in patients with heart failure with preserved ejection fraction","volume":"14","author":"Lin","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"20","key":"10.1016\/j.jfma.2026.08.032_bib21","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jacc.2025.05.008","article-title":"ACC scientific statement on the management of obesity in adults with heart failure: a report of the American College of cardiology","volume":"86","author":"Kittleson","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2026.08.032_bib22","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S2213-8587(22)00308-4","volume":"10","author":"Mc Causland","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jfma.2026.08.032_bib23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCULATIONAHA.122.059785","article-title":"Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes","volume":"146","author":"Filippatos","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2026.08.032_bib24","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/CIRCULATIONAHA.123.065134","article-title":"Cardiac and metabolic effects of dapagliflozin in heart failure with preserved ejection fraction: the CAMEO-DAPA trial","volume":"148","author":"Borlaug","year":"2023","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jfma.2026.08.032_bib25","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1161\/CIRCULATIONAHA.124.069479","article-title":"Effects of dapagliflozin on body composition and its relation to hemodynamics in heart failure with preserved ejection fraction","volume":"149","author":"Naser","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2026.08.032_bib26","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1186\/s12872-025-05127-3","article-title":"The role of SGLT2 inhibitors in heart failure with preserved ejection fraction (HFpEF): a systematic review and meta-analysis of randomized controlled trials","volume":"25","author":"Minisy","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jfma.2026.08.032_bib27","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2026.08.032_bib28","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2026.08.032_bib29","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","article-title":"Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials","volume":"403","author":"Butler","year":"2024","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jfma.2026.08.032_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102660","article-title":"Semaglutide and exercise function in obesity-related HFpEF: insights from the STEP-HFpEF Program","volume":"13","author":"Borlaug","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jfma.2026.08.032_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2213-8587(24)00304-8","article-title":"Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial","volume":"13","author":"Davies","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jfma.2026.08.032_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jfma.2026.08.032_bib33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jacc.2024.11.001","article-title":"Tirzepatide reduces LV mass and paracardiac adipose tissue in obesity-related heart failure: SUMMIT CMR substudy","volume":"85","author":"Kramer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2026.08.032_bib34","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41591-024-03374-z","article-title":"Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial","volume":"31","author":"Borlaug","year":"2025","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.jfma.2026.08.032_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011693","article-title":"Identifying the mechanisms of a peripherally limited exercise phenotype in patients with heart failure with preserved ejection fraction","volume":"17","author":"Skow","year":"2024","journal-title":"Circ Heart Fail"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626008211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626008211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T05:46:08Z","timestamp":1787291168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664626008211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"alternative-id":["S0929664626008211"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2026.08.032","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utilization of CPET in obesity-associated unexplained exertional dyspnea: Narrative review and expert perspective","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2026.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2026, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}